SH-02 · Recalibrate
Tirzepatide 10mg (2mL)
Dual-pathway metabolic support
Tirzepatide is a once-weekly therapy that acts on two metabolic receptors — GLP-1 and GIP — within a physician-directed program. It is designed to help support appetite regulation and metabolic health through dual-pathway activity, guided by your labs and structured titration.
$399 /mo
Member Pricing
Vial · Weekly injection
Rx only · pharmacy-dispensed
No payment today — a physician confirms eligibility from your labs first.
01 — How It Works
The mechanism, in plain terms.
How Tirzepatideactually works in the body — reviewed by a physician before it's ever prescribed for you.
Tirzepatide engages both the GLP-1 and GIP receptors, two complementary signals your body uses in appetite and metabolic regulation — the basis for its dual-pathway framing.
Like GLP-1 therapy, it can help support a more regulated appetite and a longer sense of satiety after meals, which many members find makes consistent habits easier to hold.
Acting on both receptors supports the body's response to rising blood sugar, which is why your physician reviews your metabolic biomarkers before and throughout therapy.
02 — The Essentials
What to know before you start.
Who it's for
Physicians typically consider tirzepatide for adults in a physician-directed metabolic program — often those who want dual-pathway support — when their labs, history, and goals indicate it is clinically appropriate.
How it's used
Self-administered as a once-weekly subcutaneous injection on the same day each week. Your physician begins at a low dose and titrates upward on a defined schedule to help support tolerability.
What's included
- Physician consultation and prescription review
- Once-weekly tirzepatide, pharmacy-dispensed
- Structured titration schedule from your physician
- Step-by-step dosing guide and injection supplies
- Secure messaging with your care team
Important — Please Read
As with all GLP-1-class therapies, nausea and digestive changes are commonly reported during titration, which is why dosing starts low and increases gradually under physician oversight.
Compounded medications are prepared by licensed pharmacies pursuant to a prescription and are not FDA-approved; the FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed.
Synergic Health Solutions is a telehealth platform connecting patients with independent, licensed physicians. Content on this site is for informational purposes only and is not medical advice, diagnosis, or treatment. Prescriptions are issued only when a licensed physician determines a therapy is clinically appropriate. Individual results vary.
03 — Questions
Straight answers.
The questions members ask most about Tirzepatide — answered the way your care team would answer them.
Tirzepatide acts on two receptor pathways (GLP-1 and GIP), while semaglutide acts on one (GLP-1). Which is clinically appropriate for you is a decision your physician makes based on your labs, history, and goals during your consultation — not a one-size answer.
Your physician reviews a baseline metabolic panel before prescribing and rechecks relevant biomarkers over time, since dosing follows your data rather than a fixed script. Your annotated lab report is part of how your protocol is adjusted at each check-in.
Nausea, reduced appetite, and digestive changes are the most commonly reported, usually most noticeable during dose increases. Starting low and titrating on a schedule is designed to help support tolerability, and your care team walks through what is normal and exactly when to reach them.
04 — Continue Exploring
Related therapies.
Begin · Synergic Health Solutions
Ready to see if Tirzepatide is right for you?
Complete your intake in ten minutes. A licensed physician reviews your history and labs, then prescribes only when it's clinically appropriate.
Available in select states · Confirmed during intake · No payment due today